Core Viewpoint - The major shareholders of Ruimai Te (301367.SZ) have announced plans to reduce their holdings, which may impact the stock's performance in the market [1][2]. Shareholder Reduction Plans - Nengjin Company and its concerted action partner, Guangzhou Jinyuan, plan to reduce their holdings by up to 888,325 shares, representing 1% of the total share capital, within three months after the announcement [1]. - Hehan Investment and its concerted action partners, Shengmin Chuangtou and Nanjing Hehao, plan to reduce their holdings by up to 2,666,169 shares, representing 3% of the total share capital, within the same timeframe [2]. Shareholding Structure - Nengjin Company holds 4,480,795 shares (5.00% of total shares) and Guangzhou Jinyuan holds 753.325 shares (0.84% of total shares) [3]. - Hehan Investment holds 11,155,686 shares (12.45% of total shares), while Shengmin Chuangtou holds 5,373,515 shares (6.00% of total shares) and Nanjing Hehao holds 358.589 shares (0.40% of total shares) [3]. Reduction Methods and Quantities - Nengjin Company plans to reduce up to 135,000 shares through centralized bidding, while Guangzhou Jinyuan plans to reduce up to 753.325 shares [5]. - Hehan Investment plans to reduce up to 530.134 shares through centralized bidding, and Shengmin Chuangtou plans to reduce up to 1,777,446 shares through block trading [5]. Market Context - Ruimai Te is currently in a state of share price decline, indicating a potential market challenge for the company [9].

Group 1 - The stock price of Ruimaite (301367.SZ) closed at 79.36 yuan, with a decline of 2.17%, currently below the issue price [1] - Yihe Jiaye was listed on the Shenzhen Stock Exchange's ChiNext on November 1, 2022, with a public offering of 16 million shares, accounting for 25% of the total share capital after issuance, at an issue price of 119.88 yuan per share [1] - The total amount raised by Yihe Jiaye was 191.808 million yuan, with a net amount of 173.82674 million yuan, exceeding the originally planned fundraising by 100.02698 million yuan [1] - The original fundraising plan was 73.79976 million yuan, intended for projects including the production of 300,000 ventilators and 3.5 million sets of accessories, marketing network and brand building, medical equipment R&D center, and working capital [1] - The underwriting institution for Yihe Jiaye was China International Capital Corporation (CICC), with representatives Chen Tingting and Xie Xianming [1] - The total issuance expenses amounted to 18.30202 million yuan, including underwriting and sponsorship fees of 15.71582 million yuan [1] - On May 22, 2024, Yihe Jiaye announced a dividend plan of 10 yuan (pre-tax) per 10 shares, with a bonus issue of 4 shares, with the ex-dividend date set for May 29, 2024 [1] Group 2 - On May 21, 2025, Yihe Jiaye announced a change of company name and stock abbreviation, changing from "Beijing Yihe Jiaye Medical Technology Co., Ltd." to "Beijing Ruimaite Medical Technology Co., Ltd." while the stock code "301367" remains unchanged [2]